Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$346,498
+$283,148 QoQ
Shares Held
2,119
+482.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Mar 31, 2026CallValue
$1,046,528
CallShares
6,400
PutValue
$719,488
PutShares
4,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Alphadyne Asset Management LP holds $5,118,929 across 5 Biotechnology names. INSM ranks #3 (6.8% of the industry book) .
All Filings in INSM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $719,488 | 4,400 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $346,498 | 2,119 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,046,528 | 6,400 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $696,160 | 4,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $487,312 | 2,800 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $63,350 | 364 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||